Issues related to pharmacy and prescription drug pricing; Issues related to the Consolidated Appropriations Act, 2026 (PL 119-75); Issues related to the extension of Enhanced Advanced Premium Tax Credits (EAPTCs) in the American Rescue Plan Act (PL 117-2) and the Inflation Reduction Act (PL 117-169); Issues relating to implementation of the No Surprises Act (PL 116-260).
2026 · 1st Quarter (Jan 1 - Mar 31)
CIGNA CORPORATION AND SUBSIDIARIES
Filed by TIBER CREEK GROUP.
Open official filingSource-reported fields
Filing overview
- Type
- 1st Quarter - Report
- Posted
- Apr 20, 2026
- Income
- $90,000.00
- Expenses
- Not reported
- Registrant
- TIBER CREEK GROUP
- Filing UUID
- 170b207c-0323-46a3-87ec-654bd40457a4
- Termination date
- Not reported
Literal source text
Lobbying issues and bill citations
Pharmacy issues related to the National Defense Authorization Act for Fiscal Year 2026 (PL 119-60).
Issues related to H.R. 5582/S. 2355 - Patients Deserve Price Tags Act.
Relationship and amount limits
Bill links use only the filing year’s mathematically derived Congress plus the literal measure type and number in the issue description. Unmatched citations remain plain text. Politically.com does not join on names, infer advocacy positions, combine amendments, or calculate totals across filings.